Adrenergic Dysregulation and Pain With and Without Acute Beta-Blockade in Women With Fibromyalgia and Temporomandibular Disorder

Journal of Pain

Volumn 10, Issue 5, 2009, Pages 542-552

  Light, Kathleen C ^a   Bragdon, Edith E ^b   Grewen, Karen M ^b   Brownley, Kimberly A ^b   Girdler, Susan S ^b   Maixner, William ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

beta adrenergic; Fibromyalgia; pain; propranolol; sympathetic; temporomandibular

Indexed keywords

ADRENALIN; HYDROCORTISONE; NORADRENALIN; PLACEBO; PROPRANOLOL;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; BODY POSTURE; CARDIOVASCULAR SYMPTOM; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FIBROMYALGIA; HEART OUTPUT; HEART RATE; HUMAN; JAW DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PAIN; SPEECH; VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; FEMALE; FIBROMYALGIA; HEMODYNAMICS; HUMANS; HYDROCORTISONE; MIDDLE AGED; NOREPINEPHRINE; PAIN; PAIN MEASUREMENT; POSTURE; PROPRANOLOL; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 65349149062     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.12.006     Document Type: Article

References (63)

1. Aaron L.A., Burke M.M., and Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia and temporomandibular disorder. Arch Intern Med 160 (2000) 221-227
2. Adler G.K., Kinsley B.T., Hurwitz S., Mossey C.J., and Goldenberg D.L. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 106 (1999) 534-543
3. Arnold L.M., Pritchett Y.L., D'Souza D.N., Kajdasz D.K., Iyengar S., and Wernicke J.F. Duloxetine for the treatment of fibromyalgia in women: Pooled results from two randomized, placebo-controlled clinical trials. J Womens Health (Larchmt) 16 (2007) 1145-1156
4. Arnold L.M., Russell I.J., Diri E.W., Duan W.R., Young Jr. J.P., Sharma U., Martin S.A., Barrett J.A., and Haig G. A 14-week randomized, double-blinded, placebo-controlled monotherapy trial of pregablin in patients with fibromyalgia. J Pain 9 (2008) 792-805
5. Baron R., Schattschneider J., Binder A., Siebrecht D., and Wasner G. Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: A case-control study. Lancet 359 (2002) 1655-1660
6. Bou-Holaigah I., Calkins H., Flynn J.A., Tunin C., Chang H.C., Kan J.S., and Row P.C. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exper Rheumatol 15 (1997) 239-246
7. Bragdon E.E., Light K.C., Costello N.L., Sigurdsson A., Bunting S., Bhalang K., and Maixner W. Group differences in pain modulation: Pain-free women compared to pain-free men and to women with TMD. Pain 96 (2002) 227-237
8. Brownley K.A., Hinderliter A.L., West S.G., Girdler S.S., Sherwood A., and Light K.C. Sympathoadrenergic mechanisms in reduced hemodynamic stress responses after exercise. Med Sci Sports Exercise 35 (2003) 978-986
9. Buskila D. Fibromyalgia, chronic fatigue syndrome and myofascial pain syndrome. Curr Opin Rheumatol 13 (2001) 117-127
10. Chidlow G., Melena J., and Osborne N.N. Betaxolol, a beta-1 adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with sodium channels; comparison with other beta-adrenoceptor antagonists. Brit J Pharmacol 130 (2000) 759-766
11. Choi B., and Rowbotham M. Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain 69 (1997) 55-63
12. Clauw D.J., and Chrousos G.P. Chronic pain and fatigue syndromes: Overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 4 (1997) 134-153
13. Clauw D.J., and Crofford L.J. Chronic widespread pain and fibromyalgia: What we know and what we need to know. Best Pract Res Clin Rheumatol 17 (2003) 685-701
14. Cohen H., Neumann L., Shore M., Amir M., Cassuto Y., and Buskila D. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 29 (2000) 217-227
15. Costello N.L., Bragdon E.E., Light K.C., Sigurdsson A., Bunting S., Grewen K., and Maixner W. Temporomandibular disorder and optimism: Relationships to ischemic pain sensitivity and interleukin-6. Pain 100 (2002) 99-110
16. Crofford L.J., Young E.A., Engleberg N.C., Korszun A., Brucksch C.B., McClure L.A., Brown M.B., and Demitrack M.A. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 18 (2004) 314-325
17. De Abreu T.C., Nilner M., Thulin T., and Vallon D. Office and ambulatory blood pressure in patients with craniomandibular disorders. Acta Odontol Scand 51 (1993) 161-170
18. Diatchenko L., Slade G.D., Nackley A.G., Bhalang K., Sigurdsson A., Belfer A., Goldman D., Xu K., Shabalina S.A., Shagin D., Max M.B., Makarov S.S., and Maixner W. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14 (2005) 135-143
19. Dworkin S.F., Fricton J.R., Hollender L., Huggins K.H., LeResche L., Lund J., Mohi N., Ohrbach R., Palla S.F., Sommers E.E., Stohler C., Truelove E.L., Von Korff M., and Widmer C.G. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications critique. J Craniomandib Disord Facial Pain Oral Pain 6 (1992) 302-355
20. Dworkin S.F., and LaResche L. Temporomandibular disorder pain: Epidemiologic data. APS Bull, April/May:12 (1993)
21. Elam M., Johansson G., and Wallin B.G. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity?. Pain 48 (1992) 371-375
22. Geraud G., Lanteri-Minet M., Lucas C., and Valade D. French Society for the Study of Migraine Headaches (SFEMC): French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 26 (2004) 1305-1318
23. Furlan R., Colombo S., Perego F., Atzeni F., Diana A., Barbic F., Porta A., Pace F., Malliani A., and Sarzi-Puttini P. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J Rheumatol 32 (2005) 1787-1793
24. Girdler S.S., Hinderliter A.L., and Light K.C. Peripheral adrenergic receptor contributions to cardiovascular reactivity: Influence of race and gender. J Psychosom Res 37 (1993) 177-193
25. Giske L., Vøllestad N.K., Mengshoel A.M., Jensen J., Knardahl S., and Røe C. Attenuated adrenergic responses to exercise in women with fibromyalgia-a controlled study. Eur J Pain 12 (2008) 351-360
26. Goldstein D.S., Eisenhofer G., and Kopin I.J. Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharm Exper Therap 305 (2003) 800-811
27. Granges G., and Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36 (1993) 642-646
28. Grothe D.R., Scheckner B., and Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy 24 (2004) 621-629
29. Haasio K., Huotari M., Nissinen E., and Mannisto P.T. Tissue histopathology, clinical chemistry and behavior of adult COMT-gene disrupted mice. J Appl Toxicol 23 (2003) 213-219
30. Hamaty D., Valentine J.L., Howard R., Howard C.W., Wakefield V., and Patten M.S. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: A 5-month study. J Rheumatol 19 Suppl Nov (1989) 164-168
31. Hedenberg-Magnussen B., Ernberg M., and Kopp S. Presence of orofacial pain and temporomandibular disorder in fibromyalgia. Swed Dent J 23 (1999) 185-192
32. Huotari M., Gogos J.A., Karayiorgou M., Koponen O., Forsberg M., Raasmaja A., Hyttinen J., and Mannisto P.T. Brain catecholamine metabolism in COMT-deficient mice. Eur J Neurosci 15 (2002) 246-256
33. Inchiosa M.A., and Kizelshteyn G. Treatment of complex regional pain syndrome type I with oral phenoxybenzamine: Rationale and case reports. Pain Practice 8 (2008) 125-132
34. Katz D.L., Greene L., Ali A., and Faridi Z. The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Med Hypotheses 69 (2007) 517-525
35. Khasar S.G., McCarter G., and Levine J.D. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81 (1999) 1104-1112
36. Korzun A., Young E.A., Singer K., Carlson N.E., Brown M.B., and Crofford L. Basal circadian cortisol secretion in women with temporomandibular disorders. J Dent Res 81 (2002) 279-283
37. Kosek E., Ekholm J., and Hansson P. Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and healthy controls. Pain 64 (1996) 415-423
38. Lautenbacher S., Rollman G.B., and McCain G.A. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 59 (1994) 45-53
39. Legangneux E., Mora J.J., Spreux-Varoquaux O., Thorin I., Herrou M., Alvado G., and Gomeni C. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology 40 (2001) 290-296
40. Light A.R., Hughen R.W., Zhang J., Rainier J., Zhuqing L., and Lee J. Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP and lactate mediated by ASIC, P2X and TRPV1. J Neurophysiol 100 (2008) 1184-1201
41. Light A.R., and Levine J.D. Diminished carrageenan-induced inflammatory hyperalgesia following direct intramuscular injection of propranolol. Personal communication (2008) available upon request from alan.light@hsc.utah.edu
42. Light K.C., Turner J.R., Hinderliter A.L., Girdler S.S., and Sherwood A. Comparison of cardiac versus vascular reactors and ethnic groups in plasma epinephrine and norepinephrine responses to stress. Internat J Behav Med 3 (1994) 229-236
43. Light KC, White A, Light AR: Post-exercise dysregulation of adrenergic and sensory receptors and altered cytokine profiles in patients with chronic fatigue/fibromyalgia. Presented at the Spring Brain Conference, Palm Springs, CA, March 13, 2008
44. Linde K., and Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2 (2004) CD003225
45. Maekawa K., Clark G.T., and Kuboki T. Intramuscular hypoperfusion, adrenergic receptors, and chronic muscle pain. J Pain 3 (2002) 251-260
46. Maekawa K., Twe C., Lotaif A., Chiapelli F., and Clark G.T. Function of beta-adrenergic receptors on mononuclear cells in female patients with fibromyalgia. J Rhematol 30 (2003) 364-368
47. Maixner W., Fillingim R., Sigurdsson A., Kincaid S., and Silva S. Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: Evidence for altered temporal summation of pain. Pain 76 (1998) 71-81
48. Margoles M.S. Pain charts. Pain 8 (1980) 115-117
49. Martinez-Lavin M. Biology and therapy of fibromyalgia: Stress, the stress response system and fibromyalgia. Arthritis Res Therap 9 (2007) 216-222
50. Martinez-Lavin M., Vidal M., Barbosa R.E., Pineda C., Casanova J.M., and Nava A. Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study. BMC Musculoskelet Disord 3 (2002) 2
51. McBeth J., Chiu Y.H., Silman A.J., Ray D., Morriss R., Dickens C., Gupta A., and Macfarlane G.J. Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther 7 (2005) R992-R1000
52. Mohn C., Vassend O., and Knardahl S. Experimental pain sensitivity in women with temporomandibular disorders and pain-free controls: The relationship to orofacial muscular contraction and cardiovascular responses. Clin J Pain 24 (2008) 343-352
53. Muizelaar J.P., Kleyer M., Hertogs I.A., and DeLange D.C. Complex regional pain syndrome (reflex sympathetic dystrophy and causalgia): Management with the calcium channel blocker nifedipine and/or the alpha-sympathetic blocker phenoxybenzamine in 59 patients. Clin Neurol Neurosurg 99 (1997) 26-30
54. Okifuji A., Turk D.C., Sinclair J.D., Starz T.W., and Marcus D.A. A standardized manual tender points survey. I. Development and determination of a threshold point for the identification of positive tender points in fibromyalgia syndrome. J Rheumatol 24 (1997) 377-383
55. Perry F., Heller P.H., Kamiya J., and Levine J.D. Altered autonomic function in patients with arthritic or with chronic orofacial pain. Pain 39 (1989) 77-84
56. Price D.D., Staud R., Robinson M.E., Mauderli A.P., Cannon R., and Vierck Jr. C.J. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 99 (2002) 49-59
57. Rodrigues L.L.F.R., Oliveira M.C.G., Pelegrini-da-Silva A., de Arruda Veiga M.C.F., Parada C.A., and Tambeli C.H. Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain 7 (2006) 929-936
58. Tanahashi S., Iida H., Oda A., Osawa Y., and Dohi S. Effect of beta-adrenoceptor antagonists on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons. Anesthesiology 99 (2003) A962
59. Thieme K., and Turk D.C. Heterogeneity of psychophysiological stress responses in fibromyalgia syndrome patients. Arthritis Res Ther 8: R9 (2006)
60. White K.P., Speechley M., Harth M., and Ostbye T. The London Fibromyalgia Epidemiology Study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 26 (1999) 1570-1576
61. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P., Fam A.G., Farber S.J., Fiechtner J.J., Franklin C., Gatter R.A., Hamaty D., Lessard J., Lichtbroun A.S., Masi A.T., McCain G.A., Reynolds W.J., Romano T.J., Russell I.J., and Sheon R.P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
62. Wood P.B., Kablinger A.S., and Caldito G.S. Open trial of pindolol in the treatment of fibromyalgia. Ann Pharmacother 39 (2005) 1812-1816
63. Yunus M.B., Dailey J.W., Aldag J.C., Masi A.T., and Jobe P.C. Plasma and urinary catecholamines in primary fibromyalgia: A controlled study. J Rheumatol 19 (1992) 95-97